Mark A. Moyad

2.4k total citations
119 papers, 1.6k citations indexed

About

Mark A. Moyad is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark A. Moyad has authored 119 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark A. Moyad's work include Cancer, Lipids, and Metabolism (21 papers), Nutritional Studies and Diet (20 papers) and Complementary and Alternative Medicine Studies (16 papers). Mark A. Moyad is often cited by papers focused on Cancer, Lipids, and Metabolism (21 papers), Nutritional Studies and Diet (20 papers) and Complementary and Alternative Medicine Studies (16 papers). Mark A. Moyad collaborates with scholars based in United States, Australia and Germany. Mark A. Moyad's co-authors include Peter R. Carroll, Gregory S. Merrick, Kenneth J. Pienta, Kent E. Wallner, Robert W. Galbreath, Larry E. Robinson, James E. Montie, Julie M. Kittelsrud, Stuart G. Reeves and Edward Adamovich and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The American Journal of Medicine.

In The Last Decade

Mark A. Moyad

115 papers receiving 1.5k citations

Peers

Countries citing papers authored by Mark A. Moyad

Since Specialization

Citations

This map shows the geographic impact of Mark A. Moyad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Moyad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Moyad more than expected).

Fields of papers citing papers by Mark A. Moyad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Moyad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Moyad. The network helps show where Mark A. Moyad may publish in the future.

Co-authorship network of co-authors of Mark A. Moyad

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Moyad. A scholar is included among the top collaborators of Mark A. Moyad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Moyad. Mark A. Moyad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Short-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trial 2014 ·Research and Reports in Urology ·Mark A. Moyad, Mark C. Scholz	2
2	What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng 2012 ·Asian Journal of Andrology ·Mark A. Moyad, Kwangsung Park	15
3	Statin Clinical Trial (REALITY) for Prostate Cancer: an Over 15-Year Wait is Finally Over Thanks to a Dietary Supplement 2011 ·Urologic Clinics of North America ·Mark A. Moyad, Laurence Klotz	6
4	The Optimal Male Health Diet and Dietary Supplement Program 2011 ·Urologic Clinics of North America ·Mark A. Moyad	4
5	Heart Health = Urologic Health and Heart Unhealthy = Urologic Unhealthy: Rapid Review of Lifestyle Changes and Dietary Supplements 2011 ·Urologic Clinics of North America ·Mark A. Moyad	5
6	Immunogenic Yeast-Based Fermentate for Cold/Flu-like Symptoms in Nonvaccinated Individuals 2010 ·The Journal of Alternative and Complementary Medicine ·Mark A. Moyad, Larry E. Robinson, Edward T. Zawada, Julie M. Kittelsrud, Ding‐Geng Chen, Stuart G. Reeves, Susan H. Weaver	28
7	Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial 2009 ·Advances in Therapy ·Mark A. Moyad, Larry E. Robinson, Julie M. Kittelsrud, Stuart G. Reeves, Susan E. Weaver, (unknown), Mark E. Bubak	31
8	Conventional, complementary, and alternative options for seasonal allergies. 2008 ·PubMed ·Mark A. Moyad	2
9	Alternative medicine utilization by African Americans and improving life expectancy: is there a correlation? 2007 ·PubMed ·Mark A. Moyad, (unknown), (unknown)	1
10	What happened to the Provenge (Sipuleucel-T) vaccine for hormone refractory prostate cancer? 2007 ·PubMed ·Mark A. Moyad	3
11	An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part II 2005 ·Urologic Oncology Seminars and Original Investigations ·Mark A. Moyad	65
12	Statins and cholesterol lowering after a cancer diagnosis: Why not? 2005 ·Urologic Oncology Seminars and Original Investigations ·Mark A. Moyad, Gregory S. Merrick	10
13	Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I 2004 ·Urologic Clinics of North America ·Mark A. Moyad, James H. Barada, Tom F. Lue, John P. Mulhall, Irwin Goldstein, (unknown)	20
14	Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part II 2004 ·Current Opinion in Urology ·Mark A. Moyad	11
15	Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention? 2004 ·Urologic Clinics of North America ·Mark A. Moyad, Peter R. Carroll	21
16	Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II 2004 ·Urologic Clinics of North America ·Mark A. Moyad, James H. Barada, Tom F. Lue, John P. Mulhall, Irwin Goldstein, Ahmed Fawzy	25
17	Bladder cancer prevention. Part I: what do I tell my patients about lifestyle changes and dietary supplements? 2003 ·Current Opinion in Urology ·Mark A. Moyad	11
18	Osteoporosis: a rapid review of risk factors and screening methods 2003 ·Urologic Oncology Seminars and Original Investigations ·Mark A. Moyad	40
19	Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective 2002 ·Urology ·Mark A. Moyad	57
20	Lifestyle/dietary supplement partial androgen suppression and/or estrogen manipulation 2002 ·Urologic Clinics of North America ·Mark A. Moyad	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact